← Back to Search

Behavioral Intervention

Diabetes Telecoaching for Type 2 Diabetes

N/A
Recruiting
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of Type 2 Diabetes Mellitus
Living with a permanent physical disability such as spinal cord injury (SCI), spina bifida, multiple sclerosis, stroke, etc.
Must not have
Severe peripheral neuropathy
Severe untreated depression in the past six months
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 48 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trialaims to create an AI-based program to help people with disabilities better manage diabetes with personalized lifestyle changes. #diabetes #AI

Who is the study for?
This trial is for people with Type 2 Diabetes who also have a permanent physical disability like spinal cord injury or multiple sclerosis. Participants must be able to speak and read English but can't join if they've had severe heart issues, kidney failure, untreated depression recently, are in another diabetes study, don't have a smartphone, or have uncontrolled blood pressure.
What is being tested?
The study is testing an AI-assisted program called AI4DM designed to help individuals with disabilities manage their diabetes through lifestyle changes. It's compared against standard attention-control methods to see how effective it is at controlling blood sugar levels.
What are the potential side effects?
Since this trial involves a telecoaching self-management program rather than medication, traditional side effects aren't expected. However, participants may experience stress or frustration if they find the technology challenging.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with Type 2 Diabetes.
Select...
I live with a permanent physical disability like SCI or MS.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have severe nerve pain or numbness in my hands or feet.
Select...
I have not had severe untreated depression in the last 6 months.
Select...
I have not had a major heart event in the last year.
Select...
My blood pressure is not well-controlled.
Select...
I have kidney failure.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~48 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 48 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Glycemic Management
Secondary study objectives
Diabetes Quality of life
Dietary intake
Family Support
+7 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: AI4DM Intervention GroupExperimental Treatment1 Intervention
Group II: Attention-control GroupActive Control1 Intervention

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor
1,656 Previous Clinical Trials
2,444,285 Total Patients Enrolled

Media Library

AI4DM (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04927377 — N/A
Type 2 Diabetes Research Study Groups: AI4DM Intervention Group, Attention-control Group
Type 2 Diabetes Clinical Trial 2023: AI4DM Highlights & Side Effects. Trial Name: NCT04927377 — N/A
AI4DM (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04927377 — N/A
~24 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top